vanucizumab inn development code experimental humanized monoclonal antibody designed treatment vanucizumab bispecific monoclonal antibody composed two different heavy chains two different light chains one arm antibody binds based bevacizumab avastin binding vascular endothelial growth factor vegfa antibody designed inhibit vegfa simultaneously offer superior clinical benefit compared vegfa inhibition alonecitation needed drug developed genentechrochecitation needed monoclonal article stub help wikipedia expanding httpsenwikipediaorgwikivanucizumab